These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21135994)

  • 1. Photoselective vaporization combined with bipolar transurethral resection for the treatment of large prostate adenoma in high-risk patients.
    Zhao Y; Chen J; Wang M; Sun P; Li L; Zhang H; Jin X
    Saudi Med J; 2010 Dec; 31(12):1320-5. PubMed ID: 21135994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoselective laser vaporization prostatectomy versus transurethral prostate resection: a cost analysis.
    Goh AC; Gonzalez RR
    J Urol; 2010 Apr; 183(4):1469-73. PubMed ID: 20172555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial.
    Horasanli K; Silay MS; Altay B; Tanriverdi O; Sarica K; Miroglu C
    Urology; 2008 Feb; 71(2):247-51. PubMed ID: 18308094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study.
    Ruszat R; Wyler SF; Seitz M; Lehmann K; Abe C; Bonkat G; Reich O; Gasser TC; Bachmann A
    BJU Int; 2008 Nov; 102(10):1432-8; discussion 1438-9. PubMed ID: 18671785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome.
    Bachmann A; Schürch L; Ruszat R; Wyler SF; Seifert HH; Müller A; Lehmann K; Sulser T
    Eur Urol; 2005 Dec; 48(6):965-71; discussion 972. PubMed ID: 16126327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of photoselective vaporization and standard transurethral resection of the prostate on urodynamics in patients with benign prostatic hyperplasia.
    Nomura H; Seki N; Yamaguchi A; Naito S
    Int J Urol; 2009 Aug; 16(8):657-62. PubMed ID: 19602003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.
    Stovsky MD; Griffiths RI; Duff SB
    J Urol; 2006 Oct; 176(4 Pt 1):1500-6. PubMed ID: 16952668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transurethral resection (TUR) in saline plasma vaporization of the prostate vs standard TUR of the prostate: 'the better choice' in benign prostatic hyperplasia?
    Geavlete B; Multescu R; Dragutescu M; Jecu M; Georgescu D; Geavlete P
    BJU Int; 2010 Dec; 106(11):1695-9. PubMed ID: 20518763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation.
    Ruszat R; Wyler S; Forster T; Reich O; Stief CG; Gasser TC; Sulser T; Bachmann A
    Eur Urol; 2007 Apr; 51(4):1031-8; discussion 1038-41. PubMed ID: 16945475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term results of transurethral vaporization of the prostate using plasmakinetic energy.
    Kaya C; Ilktac A; Gokmen E; Ozturk M; Karaman IM
    BJU Int; 2007 Apr; 99(4):845-8. PubMed ID: 17378844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparative study on the photoselective vaporization of the prostate and transurethral electrovaporization resection of prostate for the treatment of benign prostatic hyperplasia].
    Yang Y; Hong BF; Fu WJ; Xu Y; Chen YF; Zhang CE
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):951-3. PubMed ID: 17961377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laser bladder perforation from photoselective vaporization of prostate resulting in rhabdomyolysis induced acute renal failure.
    Farag E; Baccala AA; Doutt RF; Ulchaker J; O'Hara J
    Minerva Anestesiol; 2008 Jun; 74(6):277-80. PubMed ID: 18327155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy.
    Kollmeier MA; Stock RG; Cesaretti J; Stone NN
    J Urol; 2005 Mar; 173(3):808-12. PubMed ID: 15711274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photoselective potassium-titanyl-phosphate (KTP) laser vaporization of the prostate (PVP) vs transurethral resection of the prostate (TURP).
    Malek RS
    Urology; 2008 Sep; 72(3):718-9. PubMed ID: 18597826
    [No Abstract]   [Full Text] [Related]  

  • 15. Photoselective vaporization of the prostate: a volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate.
    Kumar SM
    J Urol; 2005 Feb; 173(2):511-3. PubMed ID: 15643231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histopathologic changes due to combination of androgen deprivation and transurethral microwave thermotherapy in patients with localized prostate cancer].
    Suzuki R; Jujo Y; Koshiba K; Hoshiai O; Endo T; Aihara M; Nakajo H; Ohori M
    Hinyokika Kiyo; 2009 Feb; 55(2):79-85. PubMed ID: 19301612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical treatment of benign prostatic hypertrophy].
    Dørflinger T; Frimodt-Møller C; Schou J
    Ugeskr Laeger; 2007 May; 169(20):1895-7. PubMed ID: 17553365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Previous transurethral resection of the prostate is not a contraindication to high-dose rate brachytherapy for prostate cancer.
    Luo HL; Fang FM; Chuang YC; Chiang PH
    BJU Int; 2009 Dec; 104(11):1620-3. PubMed ID: 19624535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic dose-feedback prostate brachytherapy in patients with large prostates and/or planned transurethral surgery before implantation.
    Acher PL; Popert R; Morris SL; Potters L; Austin-Smith SL; Johnson UH; Nichol JE; Beaney RP
    BJU Int; 2007 May; 99(5):1066-71. PubMed ID: 17233801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.